Vomena-PD 2 mg/5 mL (30 mL)

Indication

Paediatric antiemetic for prevention of nausea and vomiting associated with gastroenteritis and indigestion, postoperative nausea and/or vomiting, chemotherapy-induced nausea and vomiting, and post-radiation nausea and vomiting.

Ingredients

• Ondansetron hydrochloride USP equivalent to ondansetron 2 mg/5 mL

Direction

Oral (PO), three times per day. Children 4-11 years: 4 mg (10 mL). Children under 4 years by body surface area (BSA): BSA over 1 m2 - 4 mg; 0.6-1 m2 - 3 mg; 0.3-0.6 m2 - 2 mg; under 0.3 m2 - 1 mg. Use as directed by a physician.

Side effects

• Headache
• constipation or diarrhoea
• Hypersensitivity reactions have been reported
• including in patients sensitive to other selective 5
• HT3 receptor antagonists
• Consult a doctor or pharmacist before use and stop if irritation or allergy occurs.

Precautions

• Do not use if hypersensitive to ondansetron or other 5
• HT3 receptor antagonists.
• Use after abdominal surgery or in chemotherapy
• induced nausea and vomiting may mask a progressive ileus and/or gastric distension.
• Consult a doctor or pharmacist before use and stop if irritation or allergy occurs.